Astragalus membranaceus (with ambroxol HCL) |
0.30 [0.18, 0.42]
[34] |
16.18 [12.60, 19.76] [34] |
2.51 [-0.05, 5.06]
[34] |
|
Glycyrrhiza glabra (Licorice) |
n.s. [35] |
|
|
|
Maxingshigan decoction |
|
|
13.8 [8.2, 19.4] [36] |
|
Dang Shen |
0.22 [0.13, 0.31] [37] |
|
|
|
Panax ginseng |
n.s. [38] |
|
n.s. [38] |
|
Ginseng |
0.30 [0.02, 0.58] [39] |
9.43 [3.64, 15.21]
[39] |
|
|
Zingiber officinale (Ginger) |
|
|
2.08 [1.40, 2.76] (red ginger, no
control group) [40] |
|
Ephedra sinica and rhubarb |
|
4.72 [1.19,8.25] (vs. Western
Medicine) [41] |
n.s. (but reported by reference as significant)
[41] |
|
Glycyrrhiza uralensis |
|
22 [95% CI not reported](asthmatic
patients) [42] |
|
|
San-Huang Gu-Ben Zhi-Ke |
n.s.[43] |
n.s. [43] |
n.s. [43] |
|
Huangqi
|
0.27 [0.11 , 0.43] [44]
Significant Improvement (value not accessible) [45]
|
Significant Improvement (value not accessible) [45]
|
Significant Improvement (value not accessible) [45]
|
|
Nigella (Thymoquinone) |
|
n.s. [46] |
|
|
Rhodiola |
0.25 [0.21, 0.29] [47] |
9.28 [4.41, 14.15]
[47] |
5.04 [2.64, 7.43] [47] |
|
Modified Dachengqi Decoction |
|
5.3 [1.48, 9.12] [48] |
1.55
[0.23, 2.87] [48] |
|
Crocin |
0.15 [95% CI not available] [49] |
|
n.s. [49] |
|
Zataria multiflora |
1 [50] |
|
|
|
Nepeta bracteata |
n.s. [51] |
|
n.s. [51] |
|
Nanocurcumin |
|
13.03 [7.6, 18.47] [52] |
11.62 [7.3,
15.93] [52] |
|
Ivy leaf extract |
|
n.s. [53] |
n.s. [53] |
|
Hedera helix
Ivy Leaf
|
1[54]
|
|
|
|
Solanum trilobatum |
1[55] |
|
|
|
Solanum xanthocarpum |
1[55] |
|
|
|
Inflaminat is a combination of natural ingredients black elder
(Sambucus nigra L.) berries, violet (Viola tricolor L.)
herb, and calendula (Calendula officinalis L.) flowers |
|
n.s.
[56] |
n.s. [56] |
|
Withania somnifera |
|
5.43 [2.00, 8.90] [57] |
4.93 [2.53,
7.33] [57] |
|
Chinese Herbal Medicine |
(FEV1) (MD 0.12 L; 95% CI 0.08 to 0.16)
[58] |
|
|
|
Buzhong Yiqi Tang |
|
6.66 [5.79, 7.54] [59] |
|
|
Cordyceps |
|
n.s. [60] |
7.2 [2.56, 11.84] [60] |
|
Shufeng Jiedu |
|
|
4.83 [2.56, 7.10] [61] |
|
Weijing Decoction
|
0.23 [0.16, 0.29] [62]
0.25 [0.19, 0.30] [63]
|
|
|
|
Herbal Medicine |
0.14 [0.03,0.24] [64] |
|
|
|
Qingqihuatan decoction |
0.34 [0.10, 0.58] 152) |
|
|
|
Qingkailing |
0.20 [0.06, 0.35] [65] |
|
|
|
Reduning |
0.24 [0.08, 0.40] [65] |
|
|
|
Tanreqing |
0.24 [0.19, 0.29] [65] |
|
|
|
Reduning |
0.26 [0.20, 0.32] [65] |
|
|
|
Yuxingcao |
0.73 [0.06, 1.41] [65] |
|
|
|
Chinese oral herbal paste |
|
3.09 [1.49, 4.69] [66] |
|
|
NAC |
n.s. [67] |
|
|
|
Xiaoqinglong |
0.37 [0.27, 0.46] [68] |
5.11[ 4.21, 6.00]
[68] |
|
|
Xuefu Zhuyu Decoction |
0.16 [0.06, 0.26] [69] |
|
|
|
Baduanjin |
|
|
3.45 [0.49, 6.44] [70] |
|
Liuzijue |
|
|
4.43 [1.12, 7.70] [70] |
|
Taijiquan |
|
|
4.05 [0.71, 7.34] [70] |
|
Wuqinxi |
|
|
8.62 [4.46, 13.04] [70] |
|
Bufei Granule |
0.37 [0.34, 0.40] [71] |
8.05 [3.86, 12.23]
[71] |
7.53 [4.42, 10.63] [71] |
|
Shenling Baizhu San |
n.s [72] |
n.s. [72] |
6.83 [5.40,
8.27] [72] |
|
Qingjin Huatan |
0.29 [0.08, 0.51] [73] |
|
|
|
Yiqibushenhuoxue |
|
n.s. [74] |
n.s.[74] |
|
Compound Honey Syrup (CHS)) |
0.25L [0.04, 0.46] [15] |
4.66
[0.59, 8.73] [15] |
|
5.37 L[1.36, 9.38]
[15] |
Tualang honey |
n.s.[75] |
|
n.s. .[75] |
|
Jeeva® (Plant-based Nutraceutical)
|
n.s. increase by 0.26 L [-0.12,0.64] [76] v.s. baseline
0.16 L [−0.25,0.57] [77]
|
|
n.s. 1.73[-3.74,7.21] [76] v.s. baseline
n.s. 0.67 [−1.44,3.77] [77]
|
|
Cannabis |
Increase by 0.013 L [0.006,0.020] per year of daily joint
use [78] |
FVC by 20 mL/joint-year (95% CI, 12 to 27; P
< .001), |
|
|
Glutamine
|
Positively associated with FEV1 [79].
One SD difference in metabolite levels associated with 0.026L
[0.017,0.051]L
|
|
|
|
Glycine
|
Positively associated with FEV1 [79]
One SD difference in metabolite levels associated with 0.026L
[0.017,0.051]L
|
|
|
|
Hydrocinnamate
|
Positively associated with FEV1 [79].
One SD difference in metabolite levels associated with 0.026L
[0.017,0.051]L
|
|
|
|
Resvertraol |
n.s. [80] |
|
|
|
L-carnitine |
FEV-1correlates with plasma total carnitine n COPD
patients (r=0.77) [81] |
|
|
|
N-acetyl cysteine |
0.031 [0.025,0.036]L [82] |
|
0.030[0.024,0.037] [82] |
|
Sauna |
|
|
|
PEFR 0.48 ± 0.79 L/s) vs -0.11 ± 0.72 L/s) in control
group [83] |
Umckaloabo |
n.s. [84] |
|
|
|